James Patrick Kelly Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James Patrick Kelly.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James Patrick Kelly. James Patrick Kelly is EVP & Chief Financial Officer in Vanda Pharmaceuticals Inc. ($VNDA) and SVP, CFO & Treasurer in Vanda Pharmaceuticals Inc. ($VNDA) and SVP, CFO, Sec & Treasurer in Vanda Pharmaceuticals Inc. ($VNDA) and Executive Vice-President & CFO in SUPERNUS PHARMACEUTICALS, INC. ($SUPN).
Latest Insider Trading Transactions of James Patrick Kelly
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | SUPN | SUPERNUS PHARMACEU ... | Kelly James Patrick | Executive Vice-Pres ... | Option Exercise | A | 29.61 | 15,000 | 444,150 | 15,000 | |
| Mar 04 2020 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 10.76 | 5,889 | 63,359 | 186,869 | 192.8 K to 186.9 K (-3.06 %) |
| Mar 04 2020 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 10.19 | 12,968 | 132,087 | 192,758 | 205.7 K to 192.8 K (-6.30 %) |
| Jan 06 2020 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 15.94 | 4,020 | 64,086 | 205,726 | 209.7 K to 205.7 K (-1.92 %) |
| Mar 04 2019 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 19.88 | 8,751 | 173,961 | 209,746 | 218.5 K to 209.7 K (-4.01 %) |
| Mar 04 2019 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 20.15 | 4,976 | 100,271 | 218,497 | 223.5 K to 218.5 K (-2.23 %) |
| Mar 01 2019 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Option Exercise | A | 20.62 | 70,000 | 1,443,400 | 70,000 | |
| Mar 01 2019 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Grant | A | 0.00 | 30,000 | 0 | 223,473 | 193.5 K to 223.5 K (+15.51 %) |
| Mar 02 2018 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Option Exercise | A | 18.85 | 80,000 | 1,508,000 | 80,000 | |
| Mar 02 2018 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Sell | S | 18.72 | 8,532 | 159,712 | 199,534 | 208.1 K to 199.5 K (-4.10 %) |
| Mar 02 2018 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Grant | A | 0.00 | 40,000 | 0 | 208,066 | 168.1 K to 208.1 K (+23.80 %) |
| Mar 03 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Option Exercise | A | 14.50 | 70,000 | 1,015,000 | 70,000 | |
| Mar 03 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | EVP & Chief Financi ... | Grant | A | 0.00 | 70,000 | 0 | 139,721 | 69.7 K to 139.7 K (+100.40 %) |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 7,500 | 0 | 22,500 | |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 2,344 | 0 | 0 | |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO & Treasure ... | Sell | S | 15.51 | 10,895 | 169,013 | 69,721 | 80.6 K to 69.7 K (-13.51 %) |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO & Treasure ... | Buy | M | 0.00 | 7,500 | 0 | 80,616 | 73.1 K to 80.6 K (+10.26 %) |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO & Treasure ... | Buy | M | 0.00 | 5,000 | 0 | 73,116 | 68.1 K to 73.1 K (+7.34 %) |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO & Treasure ... | Buy | M | 0.00 | 5,000 | 0 | 68,116 | 63.1 K to 68.1 K (+7.92 %) |
| Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO & Treasure ... | Buy | M | 0.00 | 2,344 | 0 | 63,116 | 60.8 K to 63.1 K (+3.86 %) |
| Feb 17 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Feb 17 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | A | 7.94 | 70,000 | 555,800 | 70,000 | |
| Jan 06 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Jan 06 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
| Jan 06 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 2,344 | 0 | 2,344 | |
| Jan 06 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 4,688 | 0 | 0 | |
| Jan 06 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Sell | S | 8.96 | 9,564 | 85,693 | 60,772 | 70.3 K to 60.8 K (-13.60 %) |
| Jan 06 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 5,000 | 0 | 70,336 | 65.3 K to 70.3 K (+7.65 %) |
| Jan 06 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 5,000 | 0 | 65,336 | 60.3 K to 65.3 K (+8.29 %) |
| Jan 06 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 2,344 | 0 | 60,336 | 58 K to 60.3 K (+4.04 %) |
| Jan 06 2016 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 4,688 | 0 | 57,992 | 53.3 K to 58 K (+8.79 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 2,344 | 0 | 4,688 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 4,687 | 0 | 4,688 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Sell | S | 10.53 | 12,450 | 131,099 | 53,304 | 65.8 K to 53.3 K (-18.93 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 5,000 | 0 | 65,754 | 60.8 K to 65.8 K (+8.23 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 2,344 | 0 | 60,754 | 58.4 K to 60.8 K (+4.01 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 4,687 | 0 | 58,410 | 53.7 K to 58.4 K (+8.72 %) |
| Mar 12 2015 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 12,500 | 0 | 53,723 | 41.2 K to 53.7 K (+30.32 %) |
| Feb 21 2012 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
| Feb 21 2012 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Sell | S | 4.67 | 4,920 | 22,994 | 12,580 | 17.5 K to 12.6 K (-28.11 %) |
| Feb 21 2012 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | M | 0.00 | 12,500 | 0 | 17,500 | 5 K to 17.5 K (+250.00 %) |
| Dec 08 2011 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | A | 0.00 | 18,750 | 0 | 18,750 | |
| Dec 08 2011 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | A | 4.88 | 56,250 | 274,500 | 56,250 | |
| Aug 30 2011 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Buy | P | 5.99 | 5,000 | 29,952 | 5,000 | 0 to 5 K |
| Dec 14 2010 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Dec 14 2010 | VNDA | Vanda Pharmaceutic ... | Kelly James Patrick | SVP, CFO, Sec & Tre ... | Option Exercise | A | 8.27 | 150,000 | 1,240,500 | 150,000 |
Page: 1